Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
IRVINGTON, N.Y., Jan. 8, 2015 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, a non-invasive software-driven image analysis device approved for use in...
-
EAST LANSING, MI--(Marketwired - Jan 8, 2015) - Biophotonic Solutions Inc. (BSI), the world leader in automated laser pulse compression, announces that its "MIIPS" automated pulse compression and...
-
TORONTO, ONTARIO--(Marketwired - Dec. 16, 2014) - Spectral Diagnostics Inc. ("Spectral" or the "Company") (TSX:SDI)(OTCQX:DIAGF), a Phase III company developing the first theranostic...
-
TORONTO, ONTARIO--(Marketwired - Dec. 15, 2014) - Spectral Diagnostics Inc. ("Spectral" or the "Company") (TSX:SDI)(OTCQX:DIAGF) a Phase III company developing the first theranostic...
-
TORONTO, ONTARIO--(Marketwired - Nov. 25, 2014) - Spectral Diagnostics Inc. ("Spectral" or the "Company") (TSX:SDI)(OTCQX:DIAGF), a Phase III company developing the first theranostic...
-
IRVINGTON, N.Y., Nov. 19, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, a non-invasive software-driven image analysis device approved for use in...
-
TORONTO, ONTARIO--(Marketwired - Nov. 13, 2014) - Spectral Diagnostics Inc. ("Spectral" or the "Company") (TSX:SDI) (OTCQX:DIAGF), a Phase III company developing the first theranostic...
-
TORONTO, ONTARIO--(Marketwired - Nov. 5, 2014) - Spectral Diagnostics Inc. ("Spectral" or the "Company") (TSX:SDI) (OTCQX:DIAGF), a Phase III company developing the first theranostic...
-
Reduction of Subretinal Hyperreflective Material (SHRM) Induced by OHR-102 Correlates With Improved Vision Outcomes Regression of the SHRM Biomarker in Wet-AMD and Vision Improvement is Consistent...
-
IRVINGTON, N.Y., Sept. 15, 2014 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), developer of the MelaFind® system, a non-invasive optical diagnostic tool that assists dermatologists in the...